Published • loading... • Updated
Wall Street Pulls Back on Novo Nordisk and Jefferies While Talkspace Heads for Exit
TD Cowen cites mounting competition, patent expirations, and underwhelming drug trials as key risks leading to a 22% stock decline this year, with further pressure expected.
Summary by 247wallst.com
4 Articles
4 Articles
Wall Street Pulls Back on Novo Nordisk and Jefferies While Talkspace Heads for Exit
Quick Read Novo Nordisk (NVO) cut to Hold, $42 target, down 53.14% past year. Korn Ferry (KFY) target cut to $75. Jefferies Financial Group (JEF) target cut to $61, down 37.95% YTD. Talkspace (TALK) acquired at $5.25/share. CagriSema delivered 23% weight reduction versus Lilly’s 25.5%, failing non-inferiority while Jefferies faces First Brands legal exposure and Korn Ferry sees compressed multiples. Are you ahead, or behind on retirement? Sma…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources4
Leaning Left0Leaning Right0Center4Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium




